James Harris
Biosimilars Landscape and FDA Regulatory Expectations
March 21 by James HarrisThe Congressional Budget Office (CBO) has estimated that the United States could save $25 billion from the use of biosimilars over 10 years. In a general sense the term biosimilars refers to fo...
Patient Empowerment and Compliance:The Role of Direct to Consumer (DTC) Advertising
May 26 by James HarrisIt is a given fact that more households are wired to the internet and individuals are introduced to an onslaught of information for various venues. The internet is a tool that allows individua...